Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicine used for preventing and treating cardiovascular disease

A cardiovascular and drug technology, applied in the field of medicine, can solve problems that affect human health, take medicine for a long time, treat the symptoms but not the root cause, and achieve the effects of prolonging the survival of brain cells, improving excessive exercise fatigue, and significant myocardial tension

Inactive Publication Date: 2015-09-30
THE AFFILIATED HOSPITAL OF QINGDAO UNIV
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, although there are many medicines and liquid medicines for the treatment of cardiovascular diseases, traditional Chinese medicines have a long course of treatment, slow curative effect, and rough products; while western medicines decrease quickly, but cannot cure the symptoms, not the root cause, and have a high recurrence rate; and , Cardiovascular diseases are usually chronic diseases that require long-term treatment. Taking medicine for too long will not only cause a certain degree of damage to the liver, but also cause varying degrees of stimulation to the spleen and stomach, affecting human health.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] A medicine for treating cardiovascular disease, comprising the following raw materials in parts by weight: 33 parts of traditional Chinese medicine powder, 5 parts of ginkgo leaf extract, 5 parts of breviscapine powder, 0.4 part of nitric oxide production accelerator, 0.7 part of pyridoxine, each The drug I is obtained after the raw materials are uniformly mixed according to the proportion.

[0029] Wherein, the nitric oxide production accelerator is a mixture of 0.2 part of arginine, 0.1 part of citrulline, and 0.1 part of folic acid;

[0030] The traditional Chinese medicine powder includes the following raw materials in parts by weight: 7.5 parts of kudzu root, 7.5 parts of astragalus, 5 parts of Cyperus cyperi, 2.5 parts of curcuma, 2.5 parts of trichosanthes, 1.5 parts of pinellia, 1.5 parts of scutellaria, 0.5 parts of schisandra, 1 part of Ligustrum lucidum, 1.5 parts of medlar, 0.5 part of dodder, 1 part of epimedium, 0.5 part of psoralen.

Embodiment 2

[0032] A medicine for treating cardiovascular disease, comprising the following raw materials in parts by weight: 38 parts of traditional Chinese medicine powder, 7 parts of ginkgo leaf extract, 7 parts of breviscapine powder, 0.4 part of nitric oxide production accelerator, 0.7 part of pyridoxal, each The drug II is obtained after the raw materials are uniformly mixed according to the proportion.

[0033] Wherein, the nitric oxide production accelerator is a mixture of 0.2 part of arginine, 0.1 part of citrulline, and 0.1 part of folic acid;

[0034] The traditional Chinese medicine powder includes the following raw materials in parts by weight: 9 parts of kudzu root, 9 parts of astragalus, 6 parts of Cyperus cyperi, 3 parts of turmeric, 3 parts of Trichosanthes, 2 parts of Pinellia, 2 parts of Scutellaria baicalensis, 0.5 parts of schisandra, 1 part of Ligustrum lucidum, 1.5 parts of medlar, 0.5 part of dodder, 1 part of epimedium, 0.5 part of psoralen.

Embodiment 3

[0036] A medicine for treating cardiovascular disease, comprising the following raw materials in parts by weight: 38 parts of traditional Chinese medicine powder, 8 parts of ginkgo leaf extract, 6 parts of breviscapine powder, 0.4 part of nitric oxide production accelerator, 0.8 part of pyridoxal, each The raw materials are uniformly mixed according to the proportion to obtain the drug III.

[0037] Wherein, the nitric oxide production accelerator is a mixture of 0.2 part of arginine, 0.1 part of citrulline, and 0.1 part of folic acid;

[0038] The traditional Chinese medicine powder includes the following raw materials in parts by weight: 9 parts of kudzu root, 9 parts of astragalus, 6 parts of Cyperus cyperi, 3 parts of turmeric, 3 parts of Trichosanthes, 2 parts of Pinellia, 2 parts of Scutellaria baicalensis, 0.5 parts of schisandra, 1 part of Ligustrum lucidum, 1.5 parts of medlar, 0.5 part of dodder, 1 part of epimedium, 0.5 part of psoralen.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating cardiovascular disease. The medicine comprises the following components: 25-40 parts of herbal powder, 5-10 parts of ginkgo biloba extract, 5-10 parts of erigeron breviscapus powder, 0.2-0.5 part of a nitric oxide production accelerant, and 0.5-1 part of a platelet aggregation reducing agent. The raw materials are uniformly mixed according to the proportion, so as to obtain the medicine. The nitric oxide production accelerant is a mixture of arginine, citrulline and folic acid; the platelet aggregation reducing agent is any one of pyridoxine, pyridoxal and pyridoxamine; the herbal powder comprises the following components: 15-20 parts of radix puerariae, 15-20 parts of astragalus membranaceus, 10-15 parts of cyperus rotundus, 5-10 parts of radix curcumae, 5-10 parts of trichosanthes kirilowii, 3-5 parts of pinellia ternata, 3-5 parts of scutellaria baicalensis, 1-3 parts of schisandra chinensis, 2-4 parts of glossy privet fruit, 3-6 parts of fruit of Chinese wolfberry, 1-3 parts of semen cuscutae, 2-5 parts of herba epimedii and 1-3 parts of fructus psoraleae. The medicine provided by the invention has quick curative effect on cardiovascular disease, is short in treatment course, has good curative effect on the cardiovascular disease, and has a certain protection function on spleen, stomach and liver.

Description

technical field [0001] The invention relates to a medicine for preventing and treating cardiovascular diseases, belonging to the technical field of medicine. Background technique [0002] Cardiovascular disease, also known as circulatory system disease, is a series of diseases involving the circulatory system. The circulatory system refers to the organs and tissues that transport blood in the human body. Cardiovascular disease includes coronary heart disease and angina pectoris. Coronary heart disease and angina pectoris are caused by coronary artery disease. Insufficient blood supply, sudden and temporary myocardial ischemia, and hypoxia are caused by "chest obstruction" in traditional Chinese medicine. Since the 1950s, cardiovascular diseases such as coronary heart disease and angina pectoris have become the third leading cause of death in humans after cerebrovascular diseases and malignant tumors. [0003] At present, although there are many medicines and liquid medicine...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/06A61K36/9066A61P9/00A61P39/00A61P29/00A61P21/02A61P9/14A61P9/12A61P9/10A61P1/04A61K31/198A61K31/4415A61K31/519
Inventor 付军桦王振光时淑娟徐美玲
Owner THE AFFILIATED HOSPITAL OF QINGDAO UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products